+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

A Product and Pipeline Analysis of the Opioid Therapeutics and Drug Delivery Market

  • ID: 3110432
  • Report
  • March 2015
  • Region: Global, Global
  • 75 Pages
  • Frost & Sullivan
1 of 3
Increasing Regulation Push for Tamper-resistant Drugs Driving New Generation of Opioids

FEATURED COMPANIES

  • Actavis
  • Collegium
  • Durect
  • Endo Pharmaceuticals
  • Grünenthal
  • J&J
  • MORE
This market insight provides data for the Global Opioid Therapeutics market. The analysis looks at opioid pharmaceutical pipeline drugs currently in the market and drugs that are in Phase III stage, which pose a potential threat to competitors. It also offers a competitive analysis of the drugs, and the forecast outcome and impact of each of these drugs. Opioid drugs in the current market have a space for tamper-resistant formulations. The opioids market is segmented into relapsing neuropathic pain, acute and post-operative pain, cancer-induced pain, and moderate to severe chronic pain.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Actavis
  • Collegium
  • Durect
  • Endo Pharmaceuticals
  • Grünenthal
  • J&J
  • MORE
1. Methodology and Scope

2. Executive Summary

3. Introduction

Physician Guidelines to Opioid Therapy - Moderate to Severe Chronic Pain
Physician Guidelines to Opioid Therapy - Neuropathic Pain
Physician Guidelines to Opioid Therapy - Cancer-induced Pain
Physician Guidelines to Opioid Therapy - Acute and Post-operative Pain

4. US Opioid Therapeutics Market Overview

Introduction - Chronic Pain Prevalence by Severity
Opioid Pain Market by Region
Top-selling Products in the US Opioid Therapeutics Market
Opioid Therapeutics - Percent Sales by Type of Pain
Opioid Therapeutics - Pain Formulation Prescription Sales
Opioid Therapeutics - TRF and Non-TRF Prescription Sales
Opioid Therapeutics - Estimated Peak Sales by Route of Administration
Opioid Therapeutics Market - Pain Patch Products
Game-changing Strategies
Companies to Watch

5. Competitive Landscape

Competitive Landscape
Opioid Therapeutics Market - Competitive Landscape
Marketed Product Synopsis - Moderate to Severe Chronic Pain Opioid Therapeutics Market
Pipeline Analysis - Moderate to Severe Chronic Pain Opioid Therapeutics
Marketed Product - Neuropathic Pain Opioid Therapeutics
Pipeline Analysis - Neuropathic Pain Opioid Therapeutics
Marketed Product Synopsis - Cancer-induced Pain Opioid Therapeutics
Pipeline Analysis - Cancer-induced Pain Opioid Therapeutics
Marketed Product Synopsis - Post-operative and Acute Pain Opioid Therapeutics
Pipeline Analysis - Post-operative and Acute Pain Opioid Therapeutics
Moderate to Severe Chronic Pain Clinical Trial Design Comparison - Phase 3
Cancer-induced Pain Clinical Development Synopsis - Phase 3
Post-operative and Acute Pain Clinical Trial Design Comparison - Phase 3

6. Timeline Transparency

Estimated US Product Launch Timeline
Pre-launch Products Clinical Program - Remoxy and HYD Tablets
Pipeline Products Clinical Phase 3 Studies - BEMA Buprenorphine, COL-003, Nucynta
Pipeline Products Clinical Phase 3 Studies - Zalviso

7. Late-stage Development - Product Dashboards

Product Dashboard: Remoxy (Durect/Pain Therapeutics)
Product Dashboard: BEMA Buprenorphine (Endo Pharmaceuticals/Biodelivery)
Product Dashboard: HYD Tablet (Purdue Pharma)
Product Dashboard: COL-003/Oxycodone DETERx (Collegium)
Product Dashboard: Nucynta Extended Release (Grünenthal/J&J)
Product Dashboard: MoxDuo Immediate Release (Actavis/QRxPharma)

8. The Last Word

Legal Disclaimer
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
- Actavis
- Collegium
- Durect
- Endo Pharmaceuticals
- Grünenthal
- J&J
- Purdue Pharma
- QRxPharma

Note: Product cover images may vary from those shown
Adroll
adroll